SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/2D2AC9DC05BC9A49CB16819FD8470CA880DEF9C7324184A37B2AF520195E33E85B565B42C65192A024649C1DA1BD8DF2>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/2D2AC9DC05BC9A49CB16819FD8470CA880DEF9C7324184A37B2AF520195E33E85B565B42C65192A024649C1DA1BD8DF2
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/2D2AC9DC05BC9A49CB16819FD8470CA880DEF9C7324184A37B2AF520195E33E85B565B42C65192A024649C1DA1BD8DF2
http://www.w3.org/2000/01/rdf-schema#comment
"PTEN instability-mediated constitutive Akt activation is involved in acquired resistance mechanisms to cetuximab and also induces de novo resistance to gefitinib in non-small cell lung cancer cells."
xsd:string
http://purl.uniprot.org/uniprot/#_FCEF02FAB18DD1C29F4166050853B7B413E5DEE425CE4ED30C398688781ABA6A21C6B4277715D49F9DF06AD16193DFBE
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/2D2AC9DC05BC9A49CB16819FD8470CA880DEF9C7324184A37B2AF520195E33E85B565B42C65192A024649C1DA1BD8DF2
http://purl.uniprot.org/uniprot/F6KCZ4
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/2D2AC9DC05BC9A49CB16819FD8470CA880DEF9C7324184A37B2AF520195E33E85B565B42C65192A024649C1DA1BD8DF2
http://purl.uniprot.org/uniprot/#_F6KCZ4-mappedCitation-20444542
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/2D2AC9DC05BC9A49CB16819FD8470CA880DEF9C7324184A37B2AF520195E33E85B565B42C65192A024649C1DA1BD8DF2